Sugi Predict

Sugi Predict / Compounds / SCHEMBL4521097

SCHEMBL4521097

SCHEMBL4521097

CC(C)(C)OC(=O)N[C@H](CCC(=O)c1cccc(Cl)c1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.52
▸ PPARA Q07869 8/20 0.51
▸ PPARG P37231 7/20 0.51
▸ PPARD Q03181 2/20 0.50
▸ ACE P12821 1/20 0.48
▸ CCKBR P32239 1/20 0.47
▸ GRN P28799 1/20 0.46
▸ SORT1 Q99523 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ ERCC5 P28715 1/20 0.44
▸ FEN1 P39748 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4521105 1.00 CTSL (0.52) CTSLPPARAPPARGPPARDACE
SCHEMBL28285337 0.90 CTSL (0.48) CTSLPPARAPPARGPPARDACE
SCHEMBL2583795 0.88 ALDH1A1 (0.58) CTSLPPARAPPARGPPARDCCKBR
SCHEMBL28528396 0.88 ALDH1A1 (0.58) CTSLPPARAPPARGPPARDCCKBR
SCHEMBL20835596 0.87 PPARA (0.51) PPARAPPARGPPARDACEALDH1A1
SCHEMBL20835599 0.87 PPARA (0.51) PPARAPPARGPPARDACEALDH1A1
SCHEMBL20835705 0.87 PPARA (0.60) CTSLPPARAPPARGPPARDACE
SCHEMBL2864878 0.87 PPARA (0.60) CTSLPPARAPPARGPPARDACE
SCHEMBL2864877 0.87 PPARA (0.60) CTSLPPARAPPARGPPARDACE
SCHEMBL4524084 0.86 CTSS (0.52) PPARAPPARGPPARDACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995084-B2 Pyrrolidine derivative KISSEI PHARMACEUTICAL CO., LTD. (JP) 2021-05-04 — — US disclosed
US-20200299273-A1 PYRROLIDINE DERIVATIVE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2020-09-24 — — US disclosed
EP-3459941-A1 PYRROLIDINE DERIVATIVE Kissei Pharmaceutical Co., Ltd. (JP) 2019-03-27 — — EP disclosed
EP-1953158-B1 BICYCLIC CINNAMIDE COMPOUND EISAI R&D MAN CO LTD (JP) 2012-09-12 — — EP disclosed
US-20090181945-A1 TWO CYCLIC CINNAMIDE COMPOUND KIMURA TEIJI 2009-07-16 — — US disclosed
EP-1953158-A1 BICYCLIC CINNAMIDE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2008-08-06 — — EP disclosed
US-20070117839-A1 Two cyclic cinnamide compound EISAI R&D MANAGEMENT CO., LTD. 2007-05-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299273-A1 PYRROLIDINE DERIVATIVE CALCRL, NPY1R, GRPR CTSL 1301/4885PPARA 2471/4885PPARG 2287/4885
US-10995084-B2 Pyrrolidine derivative CALCRL, NPY1R, GRPR CTSL 1301/4885PPARA 2471/4885PPARG 2287/4885
US-20090181945-A1 TWO CYCLIC CINNAMIDE COMPOUND APP, BACE1, PSEN1 CTSL 2466/4885PPARA 1582/4885PPARG 2812/4885
US-20070117839-A1 Two cyclic cinnamide compound APP, BACE1, PSEN1 CTSL 2466/4885PPARA 1582/4885PPARG 2812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.